focusIR Fireside Chats podcast - FTSE 250 Fund Manager Reveals Hidden Emerging Market Gems | Infrastructure. Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share Price (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    0.50 (0.03%)
Bid:
1,913.00
Ask:
1,913.50
Spread: 0.50 (0.026%)
Market Cap: £76.86b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline Share Price
Price 1,915.00 Open 1,925.00
Bid 1,913.00 High 1,927.50
Ask 1,913.50 Low 1,906.00
Change 0.50 (0.03%) Close 1,914.50
Volume 3,950,795
Currency GBX
Issue Country GB
Shares in Issue 4.01b
Market Cap £76.86b
PE Ratio 13.57193
EPS 141.10
Year High 2,282.00
Year High Date 18-Feb-2026
Year Low 1,315.00
Year Low Date 18-Jul-2025
Dividend 63.00
Yield 3.29%
# Trades 8,008
Vol. Sold 2,734,191
Sold Value £52.35m
Vol. Bought 858,947
Bought Value £14.36m
Market Size 1,000
What if I invested £1,000 in Glaxosmithkline?
£ 922.89 (-7.71%)
1 month ago
£ 865.34 (-13.47%)
3 months ago
£ 1,071.03 (+7.10%)
6 months ago
£ 1,340.57 (+34.06%)
1 year ago
Add GSK to WatchlistAdd GSK to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Gsk Plc Ord 31 1/4p

Glaxosmithkline is listed in the FTSE All-Share, FTSE 350 High Yield, FTSE 350, FTSE 100 indices.

Glaxosmithkline is listed in the Medicine and Biotech sector.

Gsk Plc Ord 31 1/4p is listed on the London Stock Exchange trading with ticker code GSK.L. It has a market capitalisation of £76.86b, with approximately 4.01b shares in issue. Over the last year, Glaxosmithkline share price has been traded in a range of 967.00, hitting a high of 2,282.00, and a low of 1,315.00.

Some Videos You Might Like

What's Hot 21st April 2026


 

What's Hot early May '26


What's Hot 24th March 2026


Recent Share Trades for Glaxosmithkline (GSK)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
22-May-2615:28:231,919.000Unknown*1,913.001,913.500.00O Ordinary
Delayed publication
Was reported as OTC
22-May-2616:51:211,925.00268,103Unknown*1,913.001,913.505mO Ordinary
Was reported as OTC
22-May-2615:18:051,918.500Unknown*1,913.001,913.500.00O Ordinary
Delayed publication
Was reported as OTC
22-May-2615:18:051,918.500Unknown*1,913.001,913.500.00O Ordinary
Delayed publication
Was reported as OTC
22-May-2615:18:051,918.500Unknown*1,913.001,913.500.00O Ordinary
Delayed publication
Was reported as OTC
22-May-2615:18:051,918.500Unknown*1,913.001,913.500.00O Ordinary
Delayed publication
Was reported as OTC
22-May-2615:18:051,918.500Unknown*1,913.001,913.500.00O Ordinary
Delayed publication
Was reported as OTC
22-May-2616:43:221,915.0011Buy*1,913.001,913.50210.65O Ordinary
Trade was executed as an SI
22-May-2616:40:261,915.00107Buy*1,913.001,913.502,049O Ordinary
Trade was executed as an SI
22-May-2616:39:551,915.0030Buy*1,913.001,913.50574.50O Ordinary
Trade was executed as an SI

Directors Deals for Glaxosmithkline (GSK)

Announced Traded Action Notifier Price Currency Amount Holding
20-May-2615-May-26BuyHal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron49.67USD7415,323,778
19-May-2615-May-26Buy DividendsHal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron49.67USD2,30115,323,704
14-May-2612-May-26Transfer FromJulie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown0.00744,492
14-May-2612-May-26BuyJulie Brown held the position of Chief Finance Officer at the time of this trade.Julie Brown1,865.59GBX744,492
29-Apr-2629-Apr-26BuyWendy Becker held the position of Non-Executive Director at the time of this trade.Wendy Becker1,962.91GBX4,00021,250
Glaxosmithkline

At GSK, we unite science, technology and talent to get ahead of disease together

Glaxosmithkline Home Page